These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 25759182)
1. Translating What Works: A New Approach to Improve Diabetes Management. Phillips LS; Barb D; Yong C; Tomolo AM; Jackson SL; Olson DE; Rhee MK; Duva IM; He Q; Long Q J Diabetes Sci Technol; 2015 Jul; 9(4):857-64. PubMed ID: 25759182 [TBL] [Abstract][Full Text] [Related]
2. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Kendall DM; Riddle MC; Rosenstock J; Zhuang D; Kim DD; Fineman MS; Baron AD Diabetes Care; 2005 May; 28(5):1083-91. PubMed ID: 15855571 [TBL] [Abstract][Full Text] [Related]
3. Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study. Schernthaner G; Rosas-Guzmán J; Dotta F; Guerci B; Simó R; Festa A; Kiljański J; Zhou M; Gallwitz B Diabetes Obes Metab; 2015 Jul; 17(7):689-98. PubMed ID: 25846577 [TBL] [Abstract][Full Text] [Related]
4. Glycemic and weight changes after persistent use of incident oral diabetes therapy: a Veterans Administration retrospective cohort study. Huizinga MM; Roumie CL; Greevy RA; Liu X; Murff HJ; Hung AM; Grijalva CG; Griffin MR Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1108-12. PubMed ID: 20878643 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea. Bergenstal R; Lewin A; Bailey T; Chang D; Gylvin T; Roberts V; Curr Med Res Opin; 2009 Jan; 25(1):65-75. PubMed ID: 19210140 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes using long-term combination therapy with insulin glargine and exenatide in patients with type 2 diabetes mellitus. Levin PA; Mersey JH; Zhou S; Bromberger LA Endocr Pract; 2012; 18(1):17-25. PubMed ID: 21742605 [TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes. Diamant M; Nauck MA; Shaginian R; Malone JK; Cleall S; Reaney M; de Vries D; Hoogwerf BJ; MacConell L; Wolffenbuttel BH; Diabetes Care; 2014 Oct; 37(10):2763-73. PubMed ID: 25011946 [TBL] [Abstract][Full Text] [Related]
8. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG; Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722 [TBL] [Abstract][Full Text] [Related]
9. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients. Rosenstock J; Sugimoto D; Strange P; Stewart JA; Soltes-Rak E; Dailey G Diabetes Care; 2006 Mar; 29(3):554-9. PubMed ID: 16505505 [TBL] [Abstract][Full Text] [Related]
10. Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%. King AB; Montanya E; Pratley RE; Blonde L; Svendsen CB; Donsmark M; Sesti G Endocr Pract; 2013; 19(1):64-72. PubMed ID: 23186975 [TBL] [Abstract][Full Text] [Related]
11. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial. Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075 [TBL] [Abstract][Full Text] [Related]
12. The incretin mimetic exenatide as a monotherapy in patients with type 2 diabetes. Nelson P; Poon T; Guan X; Schnabel C; Wintle M; Fineman M Diabetes Technol Ther; 2007 Aug; 9(4):317-26. PubMed ID: 17705687 [TBL] [Abstract][Full Text] [Related]
13. The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial. Zinman B; Hoogwerf BJ; Durán García S; Milton DR; Giaconia JM; Kim DD; Trautmann ME; Brodows RG Ann Intern Med; 2007 Apr; 146(7):477-85. PubMed ID: 17404349 [TBL] [Abstract][Full Text] [Related]
14. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus. Meneghini LF; Traylor L; Schwartz SL Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924 [TBL] [Abstract][Full Text] [Related]
15. Use of concomitant glucose-lowering therapies and associated treatment results observed in clinical trials of twice-daily exenatide. Pencek R; Brunell SC; Li Y; Hoogwerf BJ; Malone J Endocr Pract; 2012; 18(2):227-37. PubMed ID: 22446132 [TBL] [Abstract][Full Text] [Related]
16. Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial. Buse JB; Bergenstal RM; Glass LC; Heilmann CR; Lewis MS; Kwan AY; Hoogwerf BJ; Rosenstock J Ann Intern Med; 2011 Jan; 154(2):103-12. PubMed ID: 21138825 [TBL] [Abstract][Full Text] [Related]
17. Exenatide twice daily versus insulin glargine for the treatment of type 2 diabetes in Poland - subgroup data from a randomised multinational trial GWAA. Matyjaszek-Matuszek B; Lenart-Lipińska M; Rogalska D; Nowakowski A; Endokrynol Pol; 2013; 64(5):375-82. PubMed ID: 24186595 [TBL] [Abstract][Full Text] [Related]
18. [Improved blood sugar control plus weight loss]. Göke B MMW Fortschr Med; 2006 Aug; 148(33-34):51. PubMed ID: 16981389 [No Abstract] [Full Text] [Related]
19. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Abdul-Ghani M; Migahid O; Megahed A; Adams J; Triplitt C; DeFronzo RA; Zirie M; Jayyousi A Diabetes Care; 2017 Mar; 40(3):325-331. PubMed ID: 28096223 [TBL] [Abstract][Full Text] [Related]
20. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study. Roberts VL; Stewart J; Issa M; Lake B; Melis R Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]